AnPac Bio-Medical Science ANPC Stock News

AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) is flying in the stock market this morning and for good reason. The company announced that it has been validating its approved COVID-19 antibody test. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

ANPC Stock Climbs On COVID-19 Antibody Test Validation

In the press release, AnPac Bio-Medical Sciences said that it has been working to further validate its COVID-19 antibody test. The test received FDA Emergency Use Authorization with expected validation completion in the second half of this year.

ANPC went on to explain that COVID-19 cases are on the rise and that there is no sign of containment. As such, it expects for testing demand to continue to rise and will continue to commit to the validation of its approved COVID-19 antibody test.

In a statement, Dr. Chris Yu, CEO at ANPC, had the following to offer:

AnPac Bio is entering into a fast growing phase of rapid new products and services development. Following the successful launch of our immunology product and CDA/ct-DNA combination test product in the first half of this year, the pending commercialization of the approved COVID-19 antibody test will be another major new product and service which AnPac Bio will offer that will accelerate our revenue growth. Our CLIA and CAP accredited clinical laboratory in the U.S. allows us to take advantage of commercial market opportunities in the U.S. by offering additional laboratory services while also continuing our research and development on our CDA technology.

This Is Great News

The news released by AnPac Bio-Medical Sciences is overwhelmingly positive. The company expects for validation to be on track with deadlines and to be able to continue to commercialize its COVID-19 testing as the pandemic leads to widespread demand.

This is a revenue growth story, and one that is worth your attention. So, give ANPC stock a look!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required


LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.